Director, Chief Scientific Officer · Edgewise Therapeutics, Inc. · Common Stock
Side
SELL
Value
$2.11M
Shares
100.0K
Price
$21.12
Executed
Nov 12, 2025
Disclosed
Nov 13, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 12 executedNov 13, 2025 disclosed
EWTX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Russell Alan J filed this Form 4 reporting a open-market sale of EWTX on Nov 12, 2025. It became public on Nov 13, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Scientific Officer
Russell Alan Jcik:0001853529
Issuer
Edgewise Therapeutics, Inc.cik:0001710072
Revision history · 0
No field has changed since this record was first ingested.
